Tomer Levy - Augmedix Senior Engineering
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Executive
Tomer Levy is Senior Engineering of Augmedix
| Age | 50 |
| Phone | 888 669 4885 |
| Web | https://www.augmedix.com |
Augmedix Management Efficiency
The company has return on total asset (ROA) of (0.3061) % which means that it has lost $0.3061 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2978) %, meaning that it created substantial loss on money invested by shareholders. Augmedix's management efficiency ratios could be used to measure how well Augmedix manages its routine affairs as well as how well it operates its assets and liabilities.Augmedix currently holds 25.85 M in liabilities with Debt to Equity (D/E) ratio of 1.54, which is about average as compared to similar companies. Augmedix has a current ratio of 2.83, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Augmedix's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 7 records | EXECUTIVE Age | ||
| Biren Shah | Elevation Oncology | N/A | |
| Dr MPH | Dermata Therapeutics | 59 | |
| Michael McNamara | In8bio Inc | N/A | |
| Sean Proehl | Dermata Therapeutics | N/A | |
| Maria MBA | Dermata Therapeutics | 73 | |
| Robert Yang | Elevation Oncology | N/A | |
| Candice Masse | Elevation Oncology | N/A | |
Management Performance
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 |
Augmedix Leadership Team
Elected by the shareholders, the Augmedix's board of directors comprises two types of representatives: Augmedix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Augmedix. The board's role is to monitor Augmedix's management team and ensure that shareholders' interests are well served. Augmedix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Augmedix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emmanuel Krakaris, CEO and President | ||
| Saurav Chatterjee, Chief Officer | ||
| Todd Holvick, Head Compliance | ||
| Jonathan Hawkins, Chief Officer | ||
| Tomer Levy, Senior Engineering | ||
| Lia Wallick, Head People | ||
| Davin MD, Chief Officer | ||
| Ian Shakil, Chief Founder | ||
| Paul Ginocchio, Chief Officer | ||
| Sandra Breber, Chief Officer |
Augmedix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Augmedix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 113.21 M | |||
| Shares Outstanding | 49.43 M | |||
| Shares Owned By Insiders | 1.50 % | |||
| Shares Owned By Institutions | 84.78 % | |||
| Number Of Shares Shorted | 1.07 M | |||
| Price To Book | 11.09 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |